SERPINB4 and SERPINB3 were also significantly upregulated [log2 (fold change) of 4.09 and 3.21], respectively) and are known to be correlated with AD severity and are increasingly recognized as a biomarker in skin inflammation (33–35) . Here, SERPINB4 is linked to dermatitis.